Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4180 | 1832 | 29.6 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
1459 | 2 | BENZODIAZEPINES//ZOLPIDEM//ZOPICLONE | 7774 |
4180 | 1 | ZOLPIDEM//ZOPICLONE//ZALEPLON | 1832 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ZOLPIDEM | authKW | 1705714 | 13% | 41% | 247 |
2 | ZOPICLONE | authKW | 1282695 | 7% | 62% | 125 |
3 | ZALEPLON | authKW | 417329 | 3% | 52% | 48 |
4 | HYPNOTICS | authKW | 344705 | 6% | 18% | 114 |
5 | TRIAZOLAM | authKW | 173948 | 3% | 20% | 53 |
6 | REBOUND INSOMNIA | authKW | 103837 | 0% | 69% | 9 |
7 | BROTIZOLAM | authKW | 102064 | 1% | 44% | 14 |
8 | SURICLONE | authKW | 96962 | 0% | 73% | 8 |
9 | N DESMETHYL ZOPICLONE | authKW | 83330 | 0% | 100% | 5 |
10 | ZOLPIDEM TARTRATE | authKW | 74994 | 0% | 75% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 18461 | 58% | 0% | 1063 |
2 | Psychiatry | 8347 | 25% | 0% | 455 |
3 | Clinical Neurology | 966 | 11% | 0% | 208 |
4 | Neurosciences | 938 | 15% | 0% | 281 |
5 | Medicine, General & Internal | 598 | 10% | 0% | 181 |
6 | Medicine, Research & Experimental | 471 | 7% | 0% | 130 |
7 | Psychology | 278 | 3% | 0% | 58 |
8 | Toxicology | 256 | 4% | 0% | 79 |
9 | Chemistry, Medicinal | 256 | 4% | 0% | 78 |
10 | Chemistry, Analytical | 249 | 6% | 0% | 119 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FOREN NEUROSCI NEUROPHARMACOL PSYCHI | 22220 | 0% | 67% | 2 |
2 | ADV SLEEP MED CARMS | 16666 | 0% | 100% | 1 |
3 | AG ARZNEIMITTELANWENDUNGFOR UNG | 16666 | 0% | 100% | 1 |
4 | ANIMA REPROD DEV | 16666 | 0% | 100% | 1 |
5 | ASSISTANCE PUBL HOP MARSEILLECPCET | 16666 | 0% | 100% | 1 |
6 | ASSISTANCE PUBL HOP MARSEILLEPHARMACOL CLIN | 16666 | 0% | 100% | 1 |
7 | BEHAV PSYCHOPHARMACOL NEUROIMAGING | 16666 | 0% | 100% | 1 |
8 | BIOSTAT PHARMACOEPIDEMIOL SUBJECT MEASUR HLTH S | 16666 | 0% | 100% | 1 |
9 | BROADMEADOWS ACUTE ADULT INPATIENT UNIT | 16666 | 0% | 100% | 1 |
10 | CARDIOMETAB CARE BIOTECH I | 16666 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH | 26056 | 1% | 12% | 13 |
2 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 15108 | 5% | 1% | 86 |
3 | SLEEP | 10616 | 3% | 1% | 53 |
4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 9706 | 3% | 1% | 53 |
5 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 9248 | 2% | 2% | 32 |
6 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 8838 | 2% | 1% | 38 |
7 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 8670 | 3% | 1% | 48 |
8 | PSYCHOPHARMACOLOGY | 6865 | 4% | 1% | 71 |
9 | TGO-TIJDSCHRIFT VOOR GENEESMIDDELENONDERZOEK-JOURNAL OF DRUG RESEARCH-JDR | 6245 | 0% | 13% | 3 |
10 | PHARMACOLOGY | 4832 | 2% | 1% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZOLPIDEM | 1705714 | 13% | 41% | 247 | Search ZOLPIDEM | Search ZOLPIDEM |
2 | ZOPICLONE | 1282695 | 7% | 62% | 125 | Search ZOPICLONE | Search ZOPICLONE |
3 | ZALEPLON | 417329 | 3% | 52% | 48 | Search ZALEPLON | Search ZALEPLON |
4 | HYPNOTICS | 344705 | 6% | 18% | 114 | Search HYPNOTICS | Search HYPNOTICS |
5 | TRIAZOLAM | 173948 | 3% | 20% | 53 | Search TRIAZOLAM | Search TRIAZOLAM |
6 | REBOUND INSOMNIA | 103837 | 0% | 69% | 9 | Search REBOUND+INSOMNIA | Search REBOUND+INSOMNIA |
7 | BROTIZOLAM | 102064 | 1% | 44% | 14 | Search BROTIZOLAM | Search BROTIZOLAM |
8 | SURICLONE | 96962 | 0% | 73% | 8 | Search SURICLONE | Search SURICLONE |
9 | N DESMETHYL ZOPICLONE | 83330 | 0% | 100% | 5 | Search N+DESMETHYL+ZOPICLONE | Search N+DESMETHYL+ZOPICLONE |
10 | ZOLPIDEM TARTRATE | 74994 | 0% | 75% | 6 | Search ZOLPIDEM+TARTRATE | Search ZOLPIDEM+TARTRATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLM, KJ , GOA, KL , (2000) ZOLPIDEM - AN UPDATE OF ITS PHARMACOLOGY, THERAPEUTIC EFFICACY AND TOLERABILITY IN THE TREATMENT OF INSOMNIA.DRUGS. VOL. 59. ISSUE 4. P. 865 -889 | 94 | 78% | 161 |
2 | WAGNER, J , WAGNER, ML , (2000) NON-BENZODIAZEPINES FOR THE TREATMENT OF INSOMNIA.SLEEP MEDICINE REVIEWS. VOL. 4. ISSUE 6. P. 551 -581 | 86 | 85% | 38 |
3 | ZAMMIT, G , (2009) COMPARATIVE TOLERABILITY OF NEWER AGENTS FOR INSOMNIA.DRUG SAFETY. VOL. 32. ISSUE 9. P. 735 -748 | 75 | 71% | 37 |
4 | DROVER, DR , (2004) COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF SHORT-ACTING HYPNOSEDATIVES - ZALEPLON, ZOLPIDEM AND ZOPICLONE.CLINICAL PHARMACOKINETICS. VOL. 43. ISSUE 4. P. 227-238 | 74 | 76% | 103 |
5 | SOLDATOS, CR , DIKEOS, DG , WHITEHEAD, A , (1999) TOLERANCE AND REBOUND INSOMNIA WITH RAPIDLY ELIMINATED HYPNOTICS: A META-ANALYSIS OF SLEEP LABORATORY STUDIES.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. VOL. 14. ISSUE 5. P. 287-303 | 82 | 73% | 69 |
6 | HARRISON, TS , KEATING, GM , (2005) ZOLPIDEM - A REVIEW OF ITS USE IN THE MANAGEMENT OF INSOMNIA.CNS DRUGS. VOL. 19. ISSUE 1. P. 65-89 | 58 | 77% | 130 |
7 | NOBLE, S , LANGTRY, HD , LAMB, HM , (1998) ZOPICLONE - AN UPDATE OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE TREATMENT OF INSOMNIA.DRUGS. VOL. 55. ISSUE 2. P. 277 -302 | 70 | 86% | 60 |
8 | GREENBLATT, DJ , ROTH, T , (2012) ZOLPIDEM FOR INSOMNIA.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 13. ISSUE 6. P. 879 -893 | 72 | 54% | 31 |
9 | TERZANO, MG , ROSSI, M , PALOMBA, V , SMERIERI, A , PARRINO, L , (2003) NEW DRUGS FOR INSOMNIA - COMPARATIVE TOLERABILITY OF ZOPICLONE, ZOLPIDEM AND ZALEPLON.DRUG SAFETY. VOL. 26. ISSUE 4. P. 261 -282 | 63 | 76% | 81 |
10 | DUNDAR, Y , BOLAND, A , STROBL, J , DODD, S , HAYCOX, A , BAGUST, A , BOGG, J , DICKSON, R , WALLEY, T , (2004) NEWER HYPNOTIC DRUGS FOR THE SHORT-TERM MANAGEMENT OF INSOMNIA: A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION.HEALTH TECHNOLOGY ASSESSMENT. VOL. 8. ISSUE 24. P. 1-+ | 80 | 62% | 31 |
Classes with closest relation at Level 1 |